Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
Niki Katsiki, Maciej Banach, Dimitri P. Mikhailidis
Archives of Medical Science (2019) Vol. 15, Iss. 6, pp. 1357-1364
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Use of Human Umbilical Vein Endothelial Cells (HUVEC) as a Model to Study Cardiovascular Disease: A Review
Diana Jhoseline Medina-Leyte, Mayra Domínguez‐Pérez, Ingrid Mercado, et al.
Applied Sciences (2020) Vol. 10, Iss. 3, pp. 938-938
Open Access | Times Cited: 177
PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on diagnosis and therapy of lipid disorders in Poland 2021
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Archives of Medical Science (2021) Vol. 17, Iss. 6, pp. 1447-1547
Open Access | Times Cited: 132
Personalized management of dyslipidemias in patients with diabetes—it is time for a new approach (2022)
Maciej Banach, Stanisław Surma, Željko Reiner, et al.
Cardiovascular Diabetology (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 64
Sodium-glucose co-transporter-2 inhibitors (SGLT2i) use and risk of amputation: an expert panel overview of the evidence
Niki Katsiki, George Dimitriadis, George Hahalis, et al.
Metabolism (2019) Vol. 96, pp. 92-100
Closed Access | Times Cited: 47
Cardiovascular outcomes trials with incretin-based medications: a critical review of data available on GLP-1 receptor agonists and DPP-4 inhibitors
Alexandros Sachinidis, Dragana Nikolić, Anca Pantea Stoian, et al.
Metabolism (2020) Vol. 111, pp. 154343-154343
Closed Access | Times Cited: 42
SGLT2 inhibitors: a focus on cardiac benefits and potential mechanisms
M Nikolić, Vladimir Živković, Jovana Joksimović Jović, et al.
Heart Failure Reviews (2021) Vol. 27, Iss. 3, pp. 935-949
Closed Access | Times Cited: 34
Predictive models and determinants of mortality among T2DM patients in a tertiary hospital in Ghana, how do machine learning techniques perform?
Godsway Edem Kpene, Sylvester Yao Lokpo, Sandra A. Darfour-Oduro
BMC Endocrine Disorders (2025) Vol. 25, Iss. 1
Open Access
In vivo and in silico study of europinidin against streptozotocin-isoproterenol-induced myocardial damage via alteration of hs-CRP/CPK-MB/Caspase-3/Bcl-2 pathways
Khalid Saad Alharbi, Muhammad Afzal, Fahad A. Al‐Abbasi, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies
Kamal Awad, Maged Mohammed, M.M. Zaki, et al.
BMC Medicine (2021) Vol. 19, Iss. 1
Open Access | Times Cited: 32
Risk-factors associated with extremely high cardiovascular risk of mid- and long-term mortality following myocardial infarction: Analysis of the Hyperlipidaemia Therapy in tERtiary Cardiological cEnTer (TERCET) registry
Krzysztof Dyrbuś, Mariusz Gąsior, Piotr Desperak, et al.
Atherosclerosis (2021) Vol. 333, pp. 16-23
Open Access | Times Cited: 27
Atherosclerotic cardiovascular disease risk stratification and management in type 2 diabetes: review of recent evidence-based guidelines
Pierre Gourdy, François Schiele, Jean‐Michel Halimi, et al.
Frontiers in Cardiovascular Medicine (2023) Vol. 10
Open Access | Times Cited: 12
Diabetes and carotid artery disease: a narrative review
Niki Katsiki, Dimitri P. Mikhailidis
Annals of Translational Medicine (2020) Vol. 8, Iss. 19, pp. 1280-1280
Open Access | Times Cited: 29
2021 PoLA/CFPiP/PCS/PSLD/PSD/PSH guidelines on the diagnosis and therapy of lipid disorders in Poland
Maciej Banach, Paweł Burchardt, Krzysztof Chlebus, et al.
Diagnostyka Laboratoryjna (2021) Vol. 57, Iss. 1, pp. 1-99
Closed Access | Times Cited: 24
Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies
Jacek Jerzy Jozwiak, Sławomir Kasperczyk, Tomasz Tomasik, et al.
Archives of Medical Science (2020)
Open Access | Times Cited: 21
The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience
Joanna Bidiuk, Zbigniew Gaciong, Piotr Sobieraj
Archives of Medical Science (2022) Vol. 18, Iss. 4, pp. 1095-1099
Open Access | Times Cited: 13
The Cardiac-Kidney-Liver (CKL) syndrome: the “real entity” of type 2 diabetes mellitus
Niki Katsiki, Genovefa Kolovou, Αndreas Μelidonis, et al.
Archives of Medical Science (2024) Vol. 20, Iss. 1, pp. 207-215
Open Access | Times Cited: 2
The effects of oral trehalose in patients with diabetes: a pilot randomized controlled trial
Somayyeh Hashemian, Mehrnaz Shojaei, Shabnam Radbakhsh, et al.
Archives of Medical Science (2023)
Open Access | Times Cited: 6
New American Diabetes Association (ADA)/European Association for the Study of Diabetes (EASD) guidelines for the pharmacotherapy of type 2 diabetes: Placing them into a practicing physician's perspective
Niki Katsiki, Ele Ferrannini, Christos S. Mantzoros
Metabolism (2020) Vol. 107, pp. 154218-154218
Closed Access | Times Cited: 15
Narrative review on clinical considerations for patients with diabetes and COVID‐19: More questions than answers
Niki Katsiki, Ricardo Gómez‐Huelgas, Dimitri P. Mikhailidis, et al.
International Journal of Clinical Practice (2021) Vol. 75, Iss. 11
Open Access | Times Cited: 13
Diabetes mellitus and comorbidities: A bad romance
Niki Katsiki, Dimitrios Tousoulis
Hellenic Journal of Cardiology (2020) Vol. 61, Iss. 1, pp. 23-25
Open Access | Times Cited: 13
Coronary Artery Calcium Score directed risk stratification of patients with Type-2 diabetes mellitus
Mahmoud Nassar, Nso Nso, Kelechi Emmanuel, et al.
Diabetes & Metabolic Syndrome Clinical Research & Reviews (2022) Vol. 16, Iss. 6, pp. 102503-102503
Closed Access | Times Cited: 5
Analysis of Risk Factors of Coronary Heart Disease and Its Correlation with Inflammatory Factors in Patients with Type 2 Diabetes Mellitus
Zhigang Wang, Hui Zhao, Qian Zhou
BioMed Research International (2022) Vol. 2022, pp. 1-9
Open Access | Times Cited: 5
Statins and diabetes mellitus progression: a fly in the ointment?
Niki Katsiki, Dimitri P. Mikhailidis
Nature Reviews Endocrinology (2021) Vol. 18, Iss. 3, pp. 137-138
Closed Access | Times Cited: 6
Subclinical Hypothyroidism as a Contributor to Macrovascular Complications in Patients with Type 2 Diabetes Mellitus
М. І. Марущак, Iryna Vivsiana, Volodymyr Musiienko, et al.
Acta Clinica Croatica (2021)
Open Access | Times Cited: 6
Associations between Inflammation, Hemoglobin Levels, and Coronary Artery Disease in Non-Albuminuric Subjects with and without Type 2 Diabetes Mellitus
Javier Donate‐Correa, Ernesto Martín‐Núñez, Carmen Mora, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 18, pp. 14131-14131
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top